FDA grants tentative OK to Ranbaxy's generic Aricept

12/7/2007 | Bloomberg

The FDA has given Indian generic drugmaker Ranbaxy Laboratories Ltd. tentative approval to market 5-mg and 10-mg tablets of donepezil hydrochloride, a version of Eisai Co. Ltd.'s Alzheimer's treatment Aricept. The Japanese drugmaker's U.S. patent for the drug expires in 2010.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL